Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GeneThera Inc

+ Add to Watchlist

GTHR:US

0.0750 USD 0.0150 25.00%

As of 20:10:00 ET on 03/04/2015.

Snapshot for GeneThera Inc (GTHR)

Open: 0.0740 Day's Range: 0.0740 - 0.0750 Volume: 40,000
Previous Close: 0.0600 52wk Range: 0.0061 - 0.0800 1-Yr Rtn: -

Stock Chart for GTHR

No chart data available.
  • GTHR:US 0.0740
  • 1D
  • 1M
  • 1Y
0.0600
Interactive GTHR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GTHR

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0300
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2.59
Shares Outstanding (M) 34.47
30 Day Average Volume 44,025
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 2.0000
Dividend Ex-Date 05/17/2007
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GTHR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GTHR

GeneThera, Inc. is a development stage molecular diagnostic company that has created a technology platform to develop and commercialize genomic assays. The Company is seeking to develop these assays to diagnose, and assist in the treatment and management of, cancerous and infectious diseases, primarily in animals, and to detect and quantify genetically modified organisms in crops.

Antonio Milici "Tony"Chairman/President/CEOTannya L IrizarryCAO/Interim CFO
More Company Profile & Key Executives for GTHR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil